Eli Lilly & Co.LLY
Closing prices as of Sep 15, 2026Updated once daily after the US close — not a live quote.

$1,138.88

-3.48% past month

Notable price movement

  • Sep 15, 2026

    $1,136.11-0.19%

    Eli Lilly said it would invest in QurCan as part of a genetic medicines deal . No other reported developments accounted for the day's modest decline in shares.

  • Sep 14, 2026

    $1,138.28+2.02%

  • Sep 11, 2026

    $1,115.7-0.65%

  • Sep 10, 2026

    $1,123-0.11%

  • Sep 9, 2026

    $1,124.21+0.03%

  • Sep 8, 2026

    $1,123.91-2.21%

    Comparable pharmaceutical companies fell 2.43% on average that day, with all six names in the group declining .

  • Sep 4, 2026

    $1,149.36-0.88%

    LLY shares declined alongside comparable pharmaceutical companies, which moved -1.28% on average with all six falling .

Closing prices for LLY. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Recent news

Seeking Alpha1 day agoEli Lilly boosted to Buy at Berenberg as upside to 2026 guidance seenThe Motley Fool1 day agoEli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change EverythingPr Newswire5 days agoLilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditionsSeeking Alpha23 hours agoScholar Rock: Reiterating 'Strong Buy' On FDA Approval SMA And Expansions Now In PlayThe Motley Fool2 days agoNovartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.Seeking Alpha23 hours agoNovo CEO seeks a more consumer-centric culture from employees

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.

Prices and financial data are historical and provided for research only. Not investment advice.